Insulet Corp Files 8-K with Exhibits

Ticker: PODD · Form: 8-K · Filed: 2025-03-18T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, financial-statements, disclosure

TL;DR

Insulet filed an 8-K, mostly standard financial docs. No major news.

AI Summary

On March 18, 2025, Insulet Corporation filed an 8-K report. The filing primarily concerns financial statements and exhibits, and a Regulation FD disclosure. No specific financial figures or new material events were detailed in the provided text.

Why It Matters

This filing indicates Insulet Corporation is providing updated financial information and disclosures to the SEC, which is standard practice for public companies.

Risk Assessment

Risk Level: low — The filing appears to be routine and does not disclose any new material adverse events or significant financial changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Insulet Corporation?

The filing is primarily for a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

On what date was this 8-K report filed?

The report was filed on March 18, 2025.

What is Insulet Corporation's principal executive office address?

The principal executive offices are located at 100 Nagog Park, Acton, Massachusetts, 01720.

What is the telephone number for Insulet Corporation?

The registrant's telephone number, including area code, is (978) 600-7000.

Under which section of the Securities Exchange Act is this 8-K filed?

This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

From the Filing

0001193125-25-056162.txt : 20250318 0001193125-25-056162.hdr.sgml : 20250318 20250318074927 ACCESSION NUMBER: 0001193125-25-056162 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250318 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250318 DATE AS OF CHANGE: 20250318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 25746506 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 d940071d8k.htm 8-K 8-K INSULET CORP false 0001145197 0001145197 2025-03-18 2025-03-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 18, 2025 INSULET CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-33462   04-3523891 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)     100 Nagog Park   Acton   Massachusetts   01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.            ☐ Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share   PODD   The NASDAQ Stock Market, LLC Item 7.01 Regulation FD Disclosure. Launch of Proposed $450 million Senior Unsecured Notes Offering On March 18, 2025, Insulet Corporation (the “Company” or “Insulet”) issued a press release announcing the proposed offering of $450 million aggregate principal amount of senior unsecured notes due 2033 (the “Notes” and the offering thereof, the “Notes Offering”) in a private placement. The Company intends to use the net proceeds from the Notes Offering, together with cash on hand and potentially cash from partially terminating the Company’s existing capped call transactions relating to the Company’s existing 0.375% Convertib

View on Read The Filing